Evoke Pharma ’s Gimoti NDA Accepted for FDA Review

SOLANA BEACH, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company ’s 505(b)(2) New Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news